Dynorphin A analogs for the treatment of chronic neuropathic pain

Future Medicinal Chemistry
Sara M HallVictor J Hruby

Abstract

Chronic pain is one of the most ubiquitous diseases in the world, but treatment is difficult with conventional methods, due to undesirable side effects of treatments and unknown mechanisms of pathological pain states. The endogenous peptide, dynorphin A has long been established as a target for the treatment of pain. Interestingly, this unique peptide has both inhibitory (opioid in nature) and excitatory activities (nonopioid) in the CNS. Both of these effects have been found to play a role in pain and much work has been done to develop therapeutics to enhance the inhibitory effects. Here we will review the dynorphin A compounds that have been designed for the modulation of pain and will discuss where the field stands today.

References

Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A GoldsteinL Hood
Apr 15, 1992·Biochemical and Biophysical Research Communications·J F HessR W Ransom
Mar 1, 1992·Trends in Neurosciences·R Dubner, M A Ruda
Jan 1, 1990·Journal of Medicinal Chemistry·H YoshinoS Tachibana
Jul 1, 1990·Journal of Medicinal Chemistry·A M KawasakiV J Hruby
Jan 1, 1991·Annual Review of Pharmacology and Toxicology·J M Bathon, D Proud
Feb 1, 1990·Trends in Pharmacological Sciences·M J Millan
May 27, 1986·European Journal of Pharmacology·L A Chahl, J S Chahl
Oct 24, 1989·European Journal of Pharmacology·D Massardier, P F Hunt
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R S ZukinA Tempel
May 1, 1985·Regulatory Peptides·A I FadenB M Cox
Aug 15, 1986·Science·A PfeifferH M Emrich
Jun 30, 1988·The New England Journal of Medicine·A LaupacisR S Roberts
Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·C Chavkin, A Goldstein
Nov 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A GoldsteinL Hood
Dec 10, 1982·Science·J M WalkerH Akil
Jan 1, 1983·Life Sciences·T KanekoH Takagi
Feb 1, 1984·British Journal of Pharmacology·A I Faden, T P Jacobs
Nov 13, 1984·European Journal of Pharmacology·J E GairinJ Cros
Oct 1, 1982·Archives of Biochemistry and Biophysics·M McIntoshB M Olivera
Dec 12, 1994·European Journal of Pharmacology·M Dumont, S Lemaire
Oct 1, 1994·Journal of Pain and Symptom Management·S Watanabe, E Bruera
Nov 1, 1993·International Journal of Peptide and Protein Research·A M KawasakiV J Hruby
Mar 19, 1993·Journal of Medicinal Chemistry·A M KawasakiV J Hruby
Oct 27, 1997·The Journal of Biological Chemistry·S Cvejic, L A Devi
Apr 1, 2000·Journal of Substance Abuse Treatment·R B RothmanJ G Liberto

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
acetylation
amidation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Sergio Canavero, Vincenzo Bonicalzi
The New England Journal of Medicine
James K Simpson
British Journal of Anaesthesia
D BridgesA S Rice
© 2021 Meta ULC. All rights reserved